Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Idiotypic Vaccination for Poor-prognosis Follicular Lymphoma Patients in First Relapse

NCT00530140 is registered in ClinicalTrials.gov with Clinica Universidad de Navarra, Universidad de Navarra as lead sponsor.

NCT NCT00530140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00530140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Idiotypic Vaccination for Poor-prognosis Follicular Lymphoma Patients in First Relapse
Lead sponsor
Clinica Universidad de Navarra, Universidad de Navarra
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2007
Completion date
September 30, 2022
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

first relapse/progression, follicular lymphoma